Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02289586
Other study ID # szkcw-2014-322
Secondary ID
Status Recruiting
Phase N/A
First received August 4, 2014
Last updated November 12, 2014
Start date July 2014

Study information

Verified date August 2014
Source Futian People's Hospital
Contact Xiao-ke Chen, Master
Phone +86-755-83982222
Email 007cxk@163.com
Is FDA regulated No
Health authority China: National Health and Family Planning Commission
Study type Interventional

Clinical Trial Summary

To evaluate the effect and safety of noninvasive ventilation assisted interventional bronchoscopy for hypoxemia patients with central airway stenosis.

With the sedation and analgesia, noninvasive ventilation assisted interventional bronchoscopy for hypoxemia patients with central airway stenosis is safe and effective, carries high satisfaction rate.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- (a)patients with central airway stenosis need interventional bronchoscopy. (b) partial pressure of arterial oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio less than 300;

Exclusion Criteria:

- (a) facial deformity sufficient to preclude mask fitting; (b) upper gastrointestinal bleeding; (c) upper airway obstruction; (d) acute coronary syndromes; (e) tracheostomy or endotracheal intubation(ETI) before admission; (f) need for urgent ETI due to cardiac or respiratory arrest.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
invasive ventilation

interventional bronchoscopy

Device:
noninvasive ventilation

Drug:
sedation(dezocine and midazolam)

general anesthesia(midazolam, fentanyl,rocuronium,propofol and Remifentanil)


Locations

Country Name City State
China Futian People's Hospital Shenzhen Guangdong

Sponsors (2)

Lead Sponsor Collaborator
Futian People's Hospital Science and Technology Innovation Commission of Shenzhen Municipality

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The improvement of airway stenosis after the operation 1 day No
Primary The improvement of partial pressure of arterial oxygen (PaO2) after the operation 1 day No
Secondary hospitalization expenses During the period of hospitalization,an expected average of 4 weeks No
Secondary hypoxemia during the operation 1 day Yes
See also
  Status Clinical Trial Phase
Completed NCT02363959 - Hyperbaric Oxygen Therapy for Lung Transplantation Phase 2
Completed NCT00672893 - Vibration Response Imaging (VRI) in Patients That Are Undergoing Pulmonary Interventional Procedure N/A